Efficacy of direct-acting antiviral therapy for hepatitis C viral infection. Real-life experience in Bahrain
Maheeba Abdulla,1 Hamed Ali,2 Hafsa Nass,2 Jawad Khamis,2 Jehad AlQamish11Gastroenterology and Hepatology, Salmaniya Medical Complex, Manama, Bahrain; 2Medical Department, Salmaniya Medical Complex, Manama, BahrainPurpose: The introduction of direct-acting antivirals (DAAs) has revolutionized the tr...
Guardado en:
Autores principales: | Abdulla M, Ali H, Nass H, Khamis J, AlQamish J |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Dove Medical Press
2019
|
Materias: | |
Acceso en línea: | https://doaj.org/article/eb27ec9cdce2439e82aef05672a0c678 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Evaluation of MicroRNA-122 as a Biomarker for Chronic Hepatitis C Infection and as a Predictor for Treatment Response to Direct-Acting Antivirals
por: Elabd NS, et al.
Publicado: (2021) -
Universal Index for Cirrhosis (UIC index): The development and validation of a novel index to predict advanced liver disease
por: Ahmed Z, et al.
Publicado: (2018) -
Interrelationship of hepatitis C virus genotypes with patient characteristics in Bahrain
por: Abdulla MA, et al.
Publicado: (2017) -
Update on blood‐based biomarkers for chronic liver diseases prognosis: Literature review and institutional experience
por: Motoh Iwasa, et al.
Publicado: (2021) -
Step by Step: Managing the Complications of Cirrhosis
por: Perez IC, et al.
Publicado: (2021)